DIN 02548887 — APIXABAN 5 MG
APIXABAN is a tablet of Apixaban marketed by SANIS HEALTH INC. The full Apixaban monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02548887
- Brand name
- APIXABAN
- Active ingredient
- Apixaban
- Strength
- 5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- SANIS HEALTH INC
- Health Canada status
- MARKETED
- Drug class
- Direct factor Xa inhibitor (anticoagulant)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Apixaban products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02487713 | ACH-APIXABAN | 2.5 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED |
| 02487721 | ACH-APIXABAN | 5 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED |
| 02529912 | AG-APIXABAN | 2.5 MG | TABLET | ANGITA PHARMA INC. | MARKETED |
| 02529920 | AG-APIXABAN | 5 MG | TABLET | ANGITA PHARMA INC. | MARKETED |
| 02530708 | APIXABAN | 2.5 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02548879 | APIXABAN | 2.5 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02530716 | APIXABAN | 5 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02487381 | APO-APIXABAN | 2.5 MG | TABLET | APOTEX INC | MARKETED |
| 02487403 | APO-APIXABAN | 5 MG | TABLET | APOTEX INC | MARKETED |
| 02486806 | AURO-APIXABAN | 2.5 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02486814 | AURO-APIXABAN | 5 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02527979 | BIO-APIXABAN | 2.5 MG | TABLET | BIOMED PHARMA | MARKETED |
| 02527987 | BIO-APIXABAN | 5 MG | TABLET | BIOMED PHARMA | MARKETED |
| 02377233 | ELIQUIS | 2.5 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02397714 | ELIQUIS | 5 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02528924 | JAMP APIXABAN | 2.5 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02528932 | JAMP APIXABAN | 5 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02529009 | M-APIXABAN | 2.5 MG | TABLET | MANTRA PHARMA INC | MARKETED |
| 02529017 | M-APIXABAN | 5 MG | TABLET | MANTRA PHARMA INC | MARKETED |
| 02492369 | MAR-APIXABAN | 2.5 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02492377 | MAR-APIXABAN | 5 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02495430 | MINT-APIXABAN | 2.5 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02495449 | MINT-APIXABAN | 5 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02492814 | NAT-APIXABAN | 2.5 MG | TABLET | NATCO PHARMA (CANADA) INC | MARKETED |
| 02492822 | NAT-APIXABAN | 5 MG | TABLET | NATCO PHARMA (CANADA) INC | MARKETED |
| 02553635 | NB-APIXABAN | 2.5 MG | TABLET | NB PHARMA INC. | MARKETED |
| 02553643 | NB-APIXABAN | 5 MG | TABLET | NB PHARMA INC. | MARKETED |
| 02526050 | NRA-APIXABAN | 2.5 MG | TABLET | NORA PHARMA INC | DORMANT |
| 02526069 | NRA-APIXABAN | 5 MG | TABLET | NORA PHARMA INC | MARKETED |
| 02546884 | NRA-APIXABAN TABLETS | 2.5 MG | TABLET | NORA PHARMA INC | MARKETED |
| 02546892 | NRA-APIXABAN TABLETS | 5 MG | TABLET | NORA PHARMA INC | MARKETED |
| 02530724 | PRO-APIXABAN | 2.5 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02530732 | PRO-APIXABAN | 5 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02525518 | RIVA APIXABAN | 2.5 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED |
| 02525526 | RIVA APIXABAN | 5 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED |
| 02489228 | SANDOZ APIXABAN SDZ | 2.5 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02489236 | SANDOZ APIXABAN SDZ | 5 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02487519 | SANDOZ APIXABAN TABLET | 2.5 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02487527 | SANDOZ APIXABAN TABLET | 5 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02510464 | TARO-APIXABAN | 2.5 MG | TABLET | SUN PHARMA CANADA INC | MARKETED |
| 02510472 | TARO-APIXABAN | 5 MG | TABLET | SUN PHARMA CANADA INC | MARKETED |
| 02484994 | TEVA-APIXABAN | 2.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02485001 | TEVA-APIXABAN | 5 MG | TABLET | TEVA CANADA LIMITED | MARKETED |